Cargando…

DR6 as a Diagnostic and Predictive Biomarker in Adult Sarcoma

BACKGROUND: The Death Receptor 6 (DR6) protein is elevated in the serum of ovarian cancer patients. We tested DR6 serum protein levels as a diagnostic/predictive biomarker in several epithelial tumors and sarcomas. METHODS: DR6 gene expression profiles were screened in publically available arrays of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Kun, Mooney, Colin, Spahlinger, Greg, Schuetze, Scott, Arias-Pulido, Hugo, Verschraegen, Claire, Gimotty, Phyllis, Buckanovich, Ronald J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342254/ https://www.ncbi.nlm.nih.gov/pubmed/22567163 http://dx.doi.org/10.1371/journal.pone.0036525

Ejemplares similares

Emerging Trends in Immunotherapy for Adult Sarcomas
por: Husain, Marium, et al.
Publicado: (2023)

Clinical markers of immunotherapy outcomes in advanced sarcoma
por: Husain, Marium, et al.
Publicado: (2023)

Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer
por: Pulaski, Heather L, et al.
Publicado: (2009)

A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma
por: Verschraegen, Claire F., et al.
Publicado: (2013)

Dr. Monro on Medullary Sarcoma of the Stomach and Intestines
Publicado: (1830)

The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab, in the treatment of melanoma
por: Verschraegen, Claire
Publicado: (2012)

Bevacizumab for the Treatment of Non-Resectable Pseudomyxoma peritonei Associated with Mucinous Ovarian Tumor of Low Malignant Potential – A Comparison of Two Cases
por: Winer, Ira, et al.
Publicado: (2009)

CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer
por: Iyengar, Mangala, et al.
Publicado: (2018)

Identification of Ferroptosis-Related Genes as Biomarkers for Sarcoma
por: Guan, Zhiyuan, et al.
Publicado: (2022)

BMPs morph into new roles in ovarian cancer
por: McLean, Karen, et al.
Publicado: (2013)

Primary Cardiac Sarcoma: A Rare, Aggressive Malignancy with a High Propensity for Brain Metastases
por: Siontis, Brittany L., et al.
Publicado: (2019)

Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment
por: Frisbie, Len, et al.
Publicado: (2022)

Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease()
por: Esper, Frank P., et al.
Publicado: (2011)

Advances in sarcoma diagnostics and treatment
por: Dancsok, Amanda R, et al.
Publicado: (2016)

In-Hospital Complications and Readmission in Patients with Hemophilia Undergoing Hip or Knee Arthroplasty
por: Chiasakul, Thita, et al.
Publicado: (2020)

Validation of LRG1 as a Potential Biomarker for Detection of Epithelial Ovarian Cancer by a Blinded Study
por: Wu, Jing, et al.
Publicado: (2015)

Metastatic biomarkers in synovial sarcoma
por: de Necochea-Campion, Rosalia, et al.
Publicado: (2017)

RNA-Sequencing of Tumor-Educated Platelets, a Novel Biomarker for Blood-Based Sarcoma Diagnostics
por: Heinhuis, Kimberley M., et al.
Publicado: (2020)

Diagnostic value of MRI signs in differentiating Ewing sarcoma from osteomyelitis
por: Kasalak, Ömer, et al.
Publicado: (2018)

Sarcoma: Molecular Pathology, Diagnostics, and Therapeutics
por: Miwa, Shinji, et al.
Publicado: (2023)

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy
por: Davis, Elizabeth J., et al.
Publicado: (2016)

The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas
por: Hagi, Tomohito, et al.
Publicado: (2017)

Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma
por: Evola, Francesco R., et al.
Publicado: (2017)

Sarcomas: New Biomarkers and Therapeutic Strategies
por: Nakamura, Tomoki
Publicado: (2021)

CCT6A, a novel prognostic biomarker for Ewing sarcoma
por: Jiang, Jie, et al.
Publicado: (2021)

Immune Prognostic Factors in Ovarian Cancer: Lessons from Translational Research
por: Gimotty, Phyllis A., et al.
Publicado: (2007)

Increased plasma DR‐70 (fibrinogen‐fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms
por: Ke, Chiao‐Hsu, et al.
Publicado: (2023)

Regulation and pharmacological targeting of RAD51 in cancer
por: Grundy, McKenzie K, et al.
Publicado: (2020)

EWSR1 Rearrangement and CD99 Expression as Diagnostic Biomarkers for Ewing/PNET Sarcomas in a Moroccan Population
por: Louati, Sara, et al.
Publicado: (2018)

The Big Yawning: Pathological Yawning as a Symptom of Neuromyelitis Optica Spectrum Disorders
por: Spahlinger, Veronika, et al.
Publicado: (2019)

Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma
por: Khorasanchi, Adam, et al.
Publicado: (2022)

Myeloid sarcoma in children – diagnostic and therapeutic difficulties
por: Samborska, Magdalena, et al.
Publicado: (2017)

Retroperitoneal Sarcomas: An Update on the Diagnostic Pathology Approach
por: Choi, Joon Hyuk, et al.
Publicado: (2020)

Isolated Myeloid Sarcoma: A Diagnostic Dilemma
por: Aslam, Hafiz M, et al.
Publicado: (2022)

THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
por: Gimotty, Phyllis A., et al.
Publicado: (2021)

Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients—A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)
por: Kasper, Bernd, et al.
Publicado: (2021)

Targeting JARID1B’s demethylase activity blocks a subset of its functions in oral cancer
por: Facompre, Nicole D., et al.
Publicado: (2017)

Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
por: Gimotty, Phyllis A., et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients
por: Zhang, Xiaohe, et al.
Publicado: (2022)

Proactive Immunotherapeutic Approaches against Inflammatory Breast Cancer May Improve Patient Outcomes
por: Alonso-Miguel, Daniel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_84si7gkp7sgbmrffl6tfvsepdm